Knee Artery Embolization Reduces Osteoarthritis Pain for 194 Patients Over One Year
A minimally invasive vascular procedure targeting abnormal blood vessels around the knee joint reduced osteoarthritis pain and improved mobility, albayan.ae reported based on research published in the journal Radiology. The study tracked 194 patients suffering from persistent knee pain despite undergoing conventional treatments such as physical therapy, anti-inflammatory medications, and intra-articular injections. The intervention, known as genicular artery embolization, uses microscopic absorbable particles to block abnormal blood vessels feeding joint inflammation, offering a potential option for patients wishing to avoid or delay surgical knee replacement.
How Genicular Artery Embolization Targets Joint Inflammation
Osteoarthritis involves the gradual breakdown of cartilage covering the ends of bones, but pain stems from multiple factors beyond cartilage damage, including joint inflammation, surrounding tissue changes, and heightened nerve sensitivity. To address these drivers, interventional radiologists guide a thin catheter through an artery using X-ray imaging to reach abnormal blood vessels in the synovial membrane surrounding the inflamed joint. Tiny gelatin microspheres are then injected to reduce blood flow and suppress inflammation-related pathways while preserving normal circulation to the joint. The microspheres are designed to dissolve within hours, ensuring they do not remain permanently inside the blood vessels, albayan.ae noted.
Clinical Trial Outcomes and One-Year Pain Scores
The trial evaluated 114 women and 80 men with a mean age of 69 years between July and November 2024, recording 239 technical procedures across cases involving one or both knees. Researchers documented technical success in all procedures without any moderate or severe complications, while mild and temporary adverse events occurred in 6.7% of cases, including transient skin discoloration and a single superficial hematoma near the catheter insertion site. To measure efficacy, patient pain was tracked on a scale from zero to 10. The median pain score dropped from 7 before treatment to 4 at six weeks, and further to 3 at six months, holding steady at 3 after one full year, according to albayan.ae findings.
Contrasting Findings and Long-Term Uncertainties
While the study demonstrates significant pain relief and improved functional scores—with daily activity metrics rising from 53 to 71.5 points and quality of life scores increasing from 19 to 40—the trial lacked a control group receiving a sham procedure or standard care alone. Consequently, researchers cannot definitively isolate the treatment effect from placebo responses. Euronews reported on a separate 2026 trial involving 292 patients that examined low-dose radiation therapy, noting a 67% reduction in adjusted disability risk and lower rates of eventual knee replacement compared to medication alone over a median follow-up of 11.9 years.
What the Research Used to Treat Knee Embolization
What specific material makes up the microspheres used in the knee embolization procedure?
Researchers utilized spherical particles made from gelatin material, which are engineered to dissolve completely within a matter of hours following the targeted vascular occlusion.
How many procedures were performed during the clinical trial period?
Physicians performed a total of 239 technical procedures during the study window between July and November 2024, which included treatments for patients suffering from osteoarthritis in one or both knees.
What percentage of patients experienced mild complications from the intervention?
Mild and temporary complications occurred in 6.7% of the total procedures, consisting of temporary skin discoloration near the treatment area and a single superficial hematoma at the catheter site.
How do alternative treatments evaluated in related studies compare regarding long-term joint health?
Euronews reported that a study examining low-dose radiotherapy alongside medications found a 67% decrease in adjusted disease-related disability risk and a lower rate of subsequent knee replacement surgery compared to medication alone over a median follow-up of 11.9 years.